|
|
 |
|
One Health News |
| |
|
| |
| Found 1196 Matching Results. View archived News Here. |
|
|
|
| Deadly infectious agents like COVID-19 are more likely as our contact with wildlife grows | Letter [OPINION] - Wednesday, April 15, 2020 |
Deadly infectious agents like COVID-19 are more likely as our contact with wildlife grows | Letter
The NJ One Health initiative started when scientists, physicians, veterinarians, public health officials, advocates and the general public realized that to ...
SEE: https://www.nj.com/opinion/2020/04/deadly-infectious-agents-like-covid-19-are-more-likely-as-our-contact-with-wildlife-grows-letter.html
"...The New Jersey Legislature is promoting this initiative by being the first state with legislation pending to commence an NJ One Health Task Force. As noted in Senate Bill S347 Legislative Statement: “One Health recognizes that the health of people is connected to the health of animals and the environment. One Health is not a new concept, but it has become increasingly important in recent years, as many factors have changed interactions between people, animals, and the environment, leading to the emergence or reemergence of many diseases. A One Health approach encourages collaborative efforts of experts working across the human, animal, and environmental health to improve the health of people and animals, including pets, livestock, and wildlife. The federal Centers for Disease Control and Prevention established a One Health Office, recognizing that the health of people is connected to the health of animals and the shared environment.”
We urge all New Jersey residents to support this important initiative.
Gloria Bachmann, MD, MMS (NJ co-chair of the Regional One Health Consortium) director, Rutgers RWJMS Women’s Health Institute, Associate Dean for Women’s Health
Amy Papi (NJ co-chair of the Regional One Health Consortium) member of the Rutgers RWJMS Women’s Health Institute and RWJUH Auxiliary Board Member
Dina Fonseca, Ph.D., director, Rutgers Center for Vector Biology
Damir Hamamdzic, DVM, Ph.D. Rutgers compliance administrator
Laura Kahn, MD, MPH, MPP, co-founder of global One Health Initiative; research scholar, Princeton University
Barbara Perry, MBA. director: RWJMS Orthopaedic Research & Education Laboratory
|
|
| Will the next coronavirus come from Amazonia? Deforestation and the risk of infectious diseases (commentary) - Thursday, April 09, 2020 |
Mongabay.org | Environmental Journalism ...
mongabay.org
April 8, 2020
Will the next coronavirus come from Amazonia? Deforestation and the risk of infectious diseases (commentary)
“... The various steps in identifying factors that contribute to the emergence and transfer of infectious diseases come under the umbrella of a “one-health perspective,” which considers the health of a human population together with the health of the surrounding populations of other species. Amazon deforestation facilitates transmission both of new diseases and of old ones like malaria. The connection between deforestation and infectious diseases is just one more impact of deforestation, added to impacts of losing both Amazonia’s biodiversity and the forest’s vital climate functions in avoiding global warming and in recycling water that is essential for non-Amazonian areas in Brazil (such as São Paulo) as well as neighboring countries like Argentina. ...”
Please read full text: https://news.mongabay.com/2020/04/will-the-next-coronavirus-come-from-amazonia-deforestation-and-the-risk-of-infectious-diseases-commentary/
Mongabay is a U.S.-based non-profit conservation and environmental science news platform. Our EIN or tax ID is 45-3714703. |
|
| "Opinion: Coronavirus outbreak stresses need for One Health and animal biotech advancement" - Executive Vice President, Food & Agriculture Biotechnology Innovation Organization (BIO) - Wednesday, April 08, 2020 |
Wednesday, April 08, 2020
Opinion: Coronavirus outbreak stresses need for One Health and animal biotech advancement
By Dana O’Brien Executive Vice President, Food & Agriculture Biotechnology Innovation Organization (BIO)
SEE: https://www.agri-pulse.com/articles/13437-opinion-coronavirus-outbreak-stresses-need-for-one-health-and-animal-biotech-advancement
“... Society was woefully unprepared for this pandemic. We must employ modern approaches to be ready for future outbreaks. One Health collaboration eliminates barriers that often exist between human health, animal health, and environmental health strategies to create smarter, multi-faceted and coordinated efforts.
BIO supports legislation such as the “Advancing Emergency Preparedness Through One Health Act of 2019.” This bill would direct the U.S. Department of Health and Human Services and the U.S. Department of Agriculture (USDA) to coordinate with other agencies and state and local leaders to advance a national One Health framework to better prevent, prepare for, and respond to zoonotic disease outbreaks like COVID-19. Congress and the White House must factor One Health into their efforts to address future pandemics.
Animal health and wellness is a critical component of One Health strategy. To help the U.S. better prepare for the future, we need changes to the U.S. animal biotechnology regulatory system. The U.S. government’s current approach to regulating animal biotechnology as a “new animal drug” has all but destroyed investment and blocked market access for a host of beneficial products. ... “
Note:
|
The COVID-19 (Coronavirus) Crisis Reinforces Necessity for Institutionalizing One Health concept/approach – Posted One Health Initiative website Tuesday, April 07, 2020
|
|
The COVID-19 (Coronavirus) crisis reinforces the essential and critical worldwide necessity for highlighting, recognizing and institutionalizing the principles of the One Health concept/approach i.e. “One Health is the collaborative efforts of multiple disciplines working locally, nationally, and globally to attain optimal health for people, animals, plants and our environment.”
The One Health concept is a worldwide strategy for expanding interdisciplinary collaborations and communications in all aspects of health care for humans, animals and the environment. The synergism achieved will advance health care for the 21st century and beyond by accelerating biomedical research discoveries, enhancing public health efficacy, expeditiously expanding the scientific knowledge base, and improving medical education and clinical care. When properly implemented, it will help protect and save untold millions of lives in our present and future generations. http://www.onehealthinitiative.com/about.php.
|
|
|
| The COVID-19 (Coronavirus) Crisis Reinforces Necessity for Institutionalizing One Health concept/approach - Tuesday, April 07, 2020 |
The COVID-19 (Coronavirus) crisis reinforces the essential and critical worldwide necessity for highlighting, recognizing and institutionalizing the principles of the One Health concept/approach i.e. “One Health is the collaborative efforts of multiple disciplines working locally, nationally, and globally to attain optimal health for people, animals, plants and our environment.”
The One Health concept is a worldwide strategy for expanding interdisciplinary collaborations and communications in all aspects of health care for humans, animals and the environment. The synergism achieved will advance health care for the 21st century and beyond by accelerating biomedical research discoveries, enhancing public health efficacy, expeditiously expanding the scientific knowledge base, and improving medical education and clinical care. When properly implemented, it will help protect and save untold millions of lives in our present and future generations. http://www.onehealthinitiative.com/about.php. |
|
| Follow Dr. Fauci's lead! ... Shut down those things right away’: Calls to close ‘wet markets’ ramp up pressure on China - Monday, April 06, 2020 |
Follow Dr. Fauci’s lead!
One Health Initiative Autonomous pro bono Team:
Laura H. Kahn, MD, MPH, MPP ▪ Bruce Kaplan, DVM ▪ Thomas P. Monath, MD ▪ Lisa A. Conti, DVM, MPH ▪ Thomas M. Yuill, PhD ▪ Helena J. Chapman, MD, MPH, PhD ▪ Craig N. Carter, DVM, PhD
‘Shut down those things right away’: Calls to close ‘wet markets’ ramp up pressure on China
Dr. Anthony Fauci, America’s top infectious disease expert, is the latest to urge countries to crack down on marketplaces like the one linked to the coronavirus outbreak.
|
|
| Life of the Mind Q&A: Laura Kahn *02 on COVID's Spread and How We Defeat It - Princeton Alumni Weekly - Saturday, April 04, 2020 |
Life of the Mind Q&A: Laura Kahn *02 on COVID's Spread and How We Defeat It
My book One Health and the Politics of Antimicrobial Resistance, and the One Health concept that I develop there and elsewhere, shows how human ...
|
|
| How to face the COVID-19 real world threat with masks? - Friday, April 03, 2020 |
How to face the COVID-19 real world threat with masks?
An important descriptive means for creating homemade face masks is carefully and intelligently described by physician public health luminary and member of the One Health Initiative team’s Advisory Board http://www.onehealthinitiative.com/advBoard.php, Virginia M. Dato, MD, MPH - Past President and webmaster American Association of Public Health Physicians (USA).
Please listen to Centers for Disease Control and Prevention’s (CDC) Emerging Infectious Disease (EID) journal’s April 2, 2020 Podcast https://tools.cdc.gov/medialibrary/index.aspx#/media/id/405814 and read the transcript https://tools.cdc.gov/podcasts/media/pdf/EID_6-06_Simple_Respiratory_Masks.pdf for directions:
Making a Simple Respiratory Mask
Dr. Virginia Dato, a physician board certified in public health and general preventive medicine, and Sarah Gregory discuss how to construct a simple respiratory face mask with easily available materials.
More info on this topic
Topics: Emergency Preparedness & Response, Personal Protective Equipment, Public Health, COVID-19, Coronavirus Disease 2019
Published: 4/2/2020
Last Updated: 4/2/2020
This podcast belongs to the CDC's Most Recent and Featured Podcasts series. |
|
| U.S.National Institute of Health/National Institute of Allergy and InfectiousDiseases (NIH/NIAID) Physician Director, Dr. Anthony S. Fauci Addresses One Health... - Tuesday, March 31, 2020 |
Since its onset, Dr. Fauci has been and is seen as one of the foremost trustworthy public health voices on the coronavirus crisis
|
U.S. National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Physician Director, Dr. Anthony S. Fauci Addresses One Health... – first POSTED One Health Initiative website Friday, March 09, 2018
|
|
U.S. National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Physician Director, Dr. Anthony S. Fauci Addresses One Health...
The One Health Initiative Autonomous pro bono Team has had many positive comments on our recent paper, “Vaccines for zoonoses: a one Health paradigm” http://www.onehealthinitiative.com/publications/2ST26%20B%20Kaplan%20-%208877.pdf published in SciTech Europa Quarterly Issue 26 – March 2018.
For example, on March 7, 2018, we heard from Dr. Tony Fauci, director of the National Institute of Allergy and Infectious Diseases, who writes, “Thank you for sharing the article about [Dr.] Tom Monath’s work. It is really well done, and captures the important contributions of our long-time friend and collaborator.
…we have long embraced a one-health paradigm at NIAID, especially in the realm of emerging and re-emerging diseases, most of which are zoonoses and must be studied in the context of the ecosystems humans share with microbes, non-human hosts, vectors, reservoirs and other actors. Many of the research efforts about which I speak and write almost daily fall under the one health rubric, in that our studies are multi-disciplinary and have benefits not only for humans but for other species, agriculture, and other aspects of society and the environment.
The Hendra virus vaccine for horses is a key example of a one health approach to the control of human disease. We supported development and evaluation of a vaccine for horses with the potential for breaking the chain of HeV transmission from bats to horses to humans, thereby protecting horse, human, and environmental health.
Certainly much of what we do in influenza is “one health” in its focus -- such as the work of Centers of Excellence for Influenza Research and Surveillance (CEIRS). And influenza vaccine research informs not only human vaccines for seasonal and pandemic flu, but also vaccines for animals.
Another important area is our Ebola work, which is focused at preventing virus transmission into the human and great ape populations, notably via vaccine development focused at protection of humans and endangered wildlife, but also by studies to understand ebolavirus spillover dynamics; by gorilla carcass surveillance (to establish the cause of great-ape mortality); and via outreach to local populations (to educate the local populations and thereby prevention of Ebola transmission into the human populations).
Our work on MERS-CoV [Middle East respiratory syndrome coronavirus] is focused on understanding the transmission of MERS-CoV into the human population and effective countermeasure design, including the development of vaccines and vaccination strategies for humans and dromedary camels. Solving the MERS-CoV spike structure has provided a potential vaccine antigen that could be applied to humans and animals (camels). Interestingly, this antigen also appears to work for other veterinary CoV like Porcine epidemic diarrhea virus (PEDV).
Studies of West Nile virus has resulted in candidate human vaccines, but also licensed equine vaccines that have been of great utility….”
_________
Note: On March 8, 2018, Dr. Fauci testified at a hearing of the U.S. Congress House Energy and Commerce Committee titled, “Examining U.S. Public Health Preparedness for and Response Efforts to Seasonal Influenza” http://bit.ly/2G6sAuo in Washington, DC (USA).
|
|
|
| Follow directives to avoid spreading COVID-19 - pictouadvocate.com Nova Scotia, Sunday, March 25, 2020 - Monday, March 30, 2020 |
| Follow directives to avoid spreading COVID-19 |
| pictouadvocate.com - Nova Scotia |
| March 25, 2020. |
|
|
|
|
| Confronting Emerging Zoonoses Book Selected as Related to COVID19 studies - Sunday, March 29, 2020 |
March 27, 2020 Notice to One Health Initiative team:
Confronting Emerging Zoonoses Book Selected as Related to COVID19 studies
*“Your Springer Book Confronting Emerging Zoonoses, especially chapters ‘One Health: From Concept to Practice’, ‘Drivers of Emerging Zoonotic Infectious Diseases’, ‘Field Epidemiology and One Health’, and ‘One Health and Food Safety’ were selected to be COVID-19 related studies and these selected resources will be available on PMC as well as WHO to help worldwide researchers currently working on the COVID-19 Pandemic.”
Free Preview
© 2014
Confronting Emerging Zoonoses
The One Health Paradigm https://www.springer.com/gp/book/9784431551195
Editors: Yamada, A., Kahn, L.H., Kaplan, B., Monath, Th.P., Woodall, J., Conti, L. (Eds.)
Free Preview Furnishes a unique resource for everyone interested in the interface of human and veterinary medicine and public health
*The full details are included in the below email:
“On March 13, the United States Office for Science and Technology Policy (OSTP) initiated a campaign which is supported by the National Science Advisors of 12 other countries. The request is to deposit all published articles (Version of Record) reporting on research results related to Covid-19 in the repositories of PubMed Central (PMC) and the World Health Organization (WHO). The campaign is asking to let researchers have free access, full reuse rights, and text and data mining (TDM) rights.
At Springer Nature, we have already been supporting earlier initiatives to give readers early access to all Covid-19 related research results. The recent campaign expands the sharing of research results which started in January. In the framework of this recent campaign we have deposited close to 9000 journal articles and 3000 book chapters on Corona viruses published over the past few years. Going forward, we will apply keyword searches to recognize newly published relevant content for further ongoing depositing.
The rights that Springer Nature and other publishers are granting to PMC and WHO will be in effect for the duration of the Covid-19 crisis, i.e. until the WHO declares the end of this Public Health Emergency of International Concern (PHEIC). We acknowledge that you may be the rights owner of some of the content we plan to deposit with PMC and the WHO. We are hoping you will support us and many other organizations in this campaign by allowing the temporary free access, full reuse rights, and TDM rights to your content, and by allowing us to deposit your Covid-19 related content in the PMC and WHO databases on your behalf.”
Emmy Lee
Associate Editor
Biomedicine & Life Science Books
Springer a part of Springer Nature
Room #204, FEBC Building, 56 Waoosan-ro, Mapo-gu
Seoul 121-707, South Korea
tel + 82 2 3142 9683
fax + 82 2 3142 5768
cell + 82 10 2775 4147
emmy.lee@springer.com
http://www.springer.com
Springer is a leading global science, technology, medicine, humanities and social sciences portfolio of innovative information, products and services, that provide researchers in academia, scientific institutions and corporate R&D departments with quality content. Springer is part of Springer Nature, one of the world’s leading global research, educational and professional publishers.
One Health Initiative Autonomous pro bono Team:
Laura H. Kahn, MD, MPH, MPP ▪ Bruce Kaplan, DVM ▪ Thomas P. Monath, MD ▪ [the late Jack Woodall, PhD] ▪ Lisa A. Conti, DVM, MPH ▪ Thomas M. Yuill, PhD ▪ Helena J. Chapman, MD, MPH, PhD ▪ Craig N. Carter, DVM, PhD
|
|
|
|
|
|
|
